Researcher.Life Logo

Clinical and Experimental Medicine : Impact Factor & More

eISSN: 1591-9528pISSN: 1591-8890

Key Metrics

CiteScore
6.9
Eigenfactor
0.001 - 0.005
H-Index
52
Impact Factor
< 5
SJR
Q1Medicine (miscellaneous)
SNIP
1.17
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical and Experimental Medicine

Clinical and Experimental Medicine Journal Specifications

Overview
Publisher SPRINGER-VERLAG ITALIA SRL
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2001
Website URLVisit website
View less

Planning to publish in Clinical and Experimental Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Experimental Medicine

Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplant.
  • 13 May 2026
  • Clinical and experimental medicine
Optimized interpretation of p53 immunohistochemistry for prediction of TP53 mutations and patient survival in DLBCL.
  • 13 May 2026
  • Clinical and experimental medicine
A prospective, open, single-arm clinical trial of fludarabine- cyclophosphamide-porcine anti-lymphocyte globulin conditioning combined with matched sibling donor hematopoietic stem cell transplantation in the treatment of severe aplastic anemia.
  • 12 May 2026
  • Clinical and experimental medicine
Natural phenolic compounds as modulators of radiation response in hepatocellular carcinoma.
  • 12 May 2026
  • Clinical and experimental medicine
Association of the RDW-to-albumin ratio with MAFLD and hepatic fibrosis in the U.S. population: a national cross-sectional study.
  • 11 May 2026
  • Clinical and experimental medicine
HSP90AA1 inhibits the Jun/Fos pathway to rescue hepatocytes from cuproptosis during ischemia-reperfusion injury.
  • 11 May 2026
  • Clinical and experimental medicine
Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplant.
  • 13 May 2026
  • Clinical and experimental medicine
Optimized interpretation of p53 immunohistochemistry for prediction of TP53 mutations and patient survival in DLBCL.
  • 13 May 2026
  • Clinical and experimental medicine
A prospective, open, single-arm clinical trial of fludarabine- cyclophosphamide-porcine anti-lymphocyte globulin conditioning combined with matched sibling donor hematopoietic stem cell transplantation in the treatment of severe aplastic anemia.
  • 12 May 2026
  • Clinical and experimental medicine
Natural phenolic compounds as modulators of radiation response in hepatocellular carcinoma.
  • 12 May 2026
  • Clinical and experimental medicine
Association of the RDW-to-albumin ratio with MAFLD and hepatic fibrosis in the U.S. population: a national cross-sectional study.
  • 11 May 2026
  • Clinical and experimental medicine
HSP90AA1 inhibits the Jun/Fos pathway to rescue hepatocytes from cuproptosis during ischemia-reperfusion injury.
  • 11 May 2026
  • Clinical and experimental medicine

FAQs on Clinical and Experimental Medicine